Señales en vivo de AVIR | Maximiza tus Ganancias con Getagraph.com

VENDER 113152 min ago

@ $3.89

Emitido: 13 feb 2024 @ 15:43

Retorno: -0.90%

Señal anterior: feb 13 - 09:30

Señal anterior: Comprar

Retorno: -4.07 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections...

Stats
Volumen de hoy	405 230
Volumen promedio	359 865
Capitalización de mercado	324.03M
EPS	$0 ( 2024-02-28 )
Próxima fecha de ganancias	( $-0.610 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.36
ATR14	$0.00500 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-31	Corcoran Andrea	Buy	44 367	Common Stock
2024-02-01	Corcoran Andrea	Sell	15 843	Common Stock
2024-01-31	Corcoran Andrea	Buy	200 000	Stock Option (Right to Buy)
2024-01-31	Corcoran Andrea	Sell	44 367	Restricted Stock Units
2024-01-31	Sommadossi Jean-pierre	Buy	448 000	Stock Option (Right to Buy)

INSIDER POWER
72.65
Last 99 transactions
Buy: 22 764 762 \| Sell: 12 804 280

Volumen Correlación

Largo: -0.09 (neutral)

Corto: -0.78 (moderate negative)

Signal:(45.286) Neutral

Atea Pharmaceuticals, Correlación

10 Correlaciones Más Positivas
TRIT	0.954
NAKD	0.953
SIRI	0.941
IMV	0.938
TNGX	0.938
JRJC	0.935
IMPL	0.935
APM	0.934
UK	0.933
GSMG	0.932

10 Correlaciones Más Negativas
KIN	-0.962
IDCC	-0.958
COUP	-0.949
TA	-0.946
PAE	-0.945
PDFS	-0.944
SLMBP	-0.944
INOD	-0.943
PEGA	-0.943
NCAC	-0.942

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Atea Pharmaceuticals, Correlación - Moneda/Commodity

-0.47
( neutral )

-0.06
( neutral )

0.00
( neutral )

0.18
( neutral )

0.00
( neutral )

0.29
( neutral )

Atea Pharmaceuticals, Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-416 000 (0.00 %)
EPS:	$-1.630

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-260 000 (0.00 %)
EPS:	$-1.390

FY	2021
Ingresos:	$351.37M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$5.61

Financial Reports:

No articles found.

Atea Pharmaceuticals,

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.